STTK Q2 2024 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena

STTKShattuck Labs, Inc.

$291M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+704.5% YoY

Gross Profit

$647,00040.2% margin

Operating Income

-$23M-1427.1% margin

Net Income

-$22M-1339.5% margin

EPS (Diluted)

$-0.42

QoQ Revenue Growth

+44.3%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$129M

Total Liabilities

$18M

Stockholders' Equity

$111M

Cash & Equivalents

$61M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$200,000	+704.5%
Gross Profit	$647,000	-$18M	+103.6%
Operating Income	-$23M	-$23M	-0.9%
Net Income	-$22M	-$21M	-1.0%

Revenue Segments

License

$2M100%